{"filing":{"accession_number":"0001193125-26-304736","cik":"0002104204","ticker":"ALMR","company_name":"Alamar Biosciences, Inc.","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"d112405d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2104204/000119312526304736/d112405d8k.htm"},"events":[{"id":18122,"run_id":16276,"accession_number":"0001193125-26-304736","anchor_item_number":"8.01","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Ian Ratcliffe, an independent director on the Board since February 2024, passed away on July 5, 2026. While the filing also mentions a board size reduction and appointment of Nicholas Naclerio to the Audit Committee, the principal disclosed event is the departure of a director due to death. This is material as it affects board composition and governance structure.","company_name":"Alamar Biosciences, Inc.","ticker":"ALMR","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":16835,"accession_number":"0001193125-26-304736","item_number":"8.01","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Ian Ratcliffe, an independent director on the Board since February 2024, passed away on July 5, 2026. While the filing also mentions a board size reduction and appointment of Nicholas Naclerio to the Audit Committee, the principal disclosed event is the departure of a director due to death. This is material as it affects board composition and governance structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T20:05:51.244687+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16835,"accession_number":"0001193125-26-304736","item_number":"8.01","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Ian Ratcliffe, an independent director on the Board since February 2024, passed away on July 5, 2026. While the filing also mentions a board size reduction and appointment of Nicholas Naclerio to the Audit Committee, the principal disclosed event is the departure of a director due to death. This is material as it affects board composition and governance structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T20:05:51.244687+00:00","company_name":"Alamar Biosciences, Inc.","ticker":"ALMR","filing_date":"2026-07-15"}]}